Alamar Biosciences
(NASDAQ) ALMR
Alamar Biosciences Financials at a Glance
Market Cap
$1.40B
Revenue (TTM)
$39.13
Net Income (TTM)
-$28.98
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$21.91
Volume
996,564
Open
$20.45
Price
$21.91
Volume
996,564
Open
$20.45
Previous Close
$21.96
Daily Range
$20.20 - $22.24
52-Week Range
$17.00 - $27.20
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$21.91
Volume
996,564
Open
$20.45
Previous Close
$21.96
Daily Range
$20.20 - $22.24
52-Week Range
$17.00 - $27.20
Estimated Earnings Date
Aug 6, 2026
ALMR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alamar Biosciences
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
250
CEO
Yu Ling Luo, PhD
Website
www.alamarbio.comHeadquarters
Fremont, CA 94538, US
ALMR Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
-42%
Net Income Margin
-40%
Return on Equity
0%
Return on Capital
-27%
Return on Assets
-21%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.40B
Shares Outstanding
69.31M
Volume
996.56K
Avg. Volume
363.46K
Financials (TTM)
Gross Profit
$41.71M
Operating Income
-$31.33M
EBITDA
-$24.89M
Operating Cash Flow
-$53.61M
Capital Expenditure
-$6.38M
Free Cash Flow
-$59.99M
Cash & ST Invst.
$30.00M
Total Debt
$41.47M
Alamar Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$26.04M
N/A
Gross Profit
$14.46M
N/A
Gross Margin
55.53%
N/A
Market Cap
$1.40B
N/A
Market Cap/Employee
$6.31M
N/A
Employees
222
N/A
Net Income
-$21.33M
N/A
EBITDA
-$19.47M
N/A
Quarterly Fundamentals
Total Cash
$64.59M
N/A
Total Debt
$340.55M
N/A
Accounts Receivable
$19.52M
N/A
Inventory
$39.93M
N/A
Long Term Debt
$338.95M
N/A
Short Term Debt
$1.60M
N/A
Return on Assets
-21.30%
N/A
Return on Invested Capital
-26.95%
N/A
Free Cash Flow
-$20.95M
N/A
Operating Cash Flow
-$20.35M
N/A